Advertisement

Organisation › Details
Bristol Myers Squibb Co. (BMS) (NYSE: BMY)
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook and Instagram. Celgene and Juno Therapeutics are wholly owned subsidiaries of Bristol-Myers Squibb Company. In certain countries outside the U.S., due to local laws, Celgene and Juno Therapeutics are referred to as, Celgene, a Bristol Myers Squibb company and Juno Therapeutics, a Bristol Myers Squibb company. *
![]() |
Start | 1989-10-04 merged |
Group | Bristol Myers Squibb (BMS) (Group) | |
![]() |
Industry | pharmaceutical |
![]() |
Region | New York, NY |
Country | United States (USA) | |
Street | 430 East 29th Street 14th Floor | |
City | 10016 New York, NY | |
Tel | +1-212-546-4000 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | H: 10,001 to 50,00 (2018-12-31) |
Currency | USD | |
Annual sales | 22,561,000,000 (revenue, total, consolidated (2018) 2018-12-31) | |
Profit | 4,947,000,000 (2018-12-31) | |
Cash | 6,911,000,000 (2018-12-31) | |
* Document for »About Section«: | ||
Record changed: 2025-01-25 |
Advertisement

More documents for Bristol Myers Squibb (BMS) (Group)
- [1] Agilent Technologies Inc.. (12/10/24). "Press Release: Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification". Santa Clara, CA....
- [2] ITM Isotope Technologies Munich SE. (6/20/24). "Press Release: ITM Appoints Dr. Andrew Cavey as CEO to Lead Organization in its Next Stage of Growth". Garching....
- [3] Evotec SE. (6/12/24). "Press Release: Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb". Hamburg....
- [4] NeoPhore Ltd.. (5/22/24). "Press Release: NeoPhore Closes Oversubscribed Series B Extension Round with Additional Funding from Bristol Myers Squibb". London....
- [5] VantAI. (2/13/24). "Press Release: VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence". New York, NY....
- [6] GlycoEra AG. (1/5/24). "Press Release: GlycoEra AG Announces New Investor, Appoints Industry Veteran Greg Fralish as Chief Business Officer". Newton, MA & Wädenswil....
- [7] Bristol Myers Squibb Company. (12/26/23). "Press Release: Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio". Princeton, NJ & San Diego, CA....
- [8] Bristol Myers Squibb Company. (12/22/23). "Press Release: Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics". Princeton, N.J. & Boston, MA....
- [9] Armstrong, Annalee / Bayer, Max / Masson, Gabrielle [Fierce Biotech]. (12/22/23). "News: Fierce Biotech M&A Tracker 2023. BMS, AbbVie Drop Billions for Neuropsychiatry Biotechs"....
- [10] RayzeBio, Inc.. (9/19/23). "Press Release: RayzeBio, Inc. Announces Closing of Upsized $358 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares". San Diego, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top